Springworks jumps after Reuters reports Merck KGaA in talks to buy company

SpringWorks Therapeutics

10/02/2025 15:35

** Cancer and rare diseases drugmaker Springworks
Therapeutics'  SWTX.O  shares surge, up about 30% to $52.70 in
morning trade
    ** Reuters reports that German healthcare and technology
group, Merck KGaA  MRCG.DE  is in advanced talks to acquire
SWTX, according to people familiar with the matter
    ** If the talks are successful, a deal could be signed in
the coming weeks, according to Reuters' sources
    ** Both Springworks and Merck declined to comment
    ** SWTX stock has risen 12% in the last 12 months

 (Reporting by Padmanabhan Ananthan)
 ((Padmanabhan.Ananthan@thomsonreuters.com;))